The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market In 2026 And 2030?

The market for renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing has experienced rapid expansion in recent years. It is projected to increase from $1.52 billion in 2025 to $1.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.7%. Historically, the market’s growth has been fueled by developments such as increased preclinical drug safety testing, a rise in nephrotoxicity related drug failures, the expansion of CRO services, elevated regulatory safety requirements, and greater adoption of in vitro assays.

The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market is projected for significant expansion in the coming years. This market is anticipated to reach $2.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This expansion during the forecast period can be primarily attributed to several factors, including the rising prevalence of biologics and intricate drugs, the wider adoption of predictive toxicology models, the growing use of organ-on-chip platforms, advancements in precision medicine research, and the increasing demand for AI-driven safety analytics. Key developments anticipated in this period encompass toxicity assays utilizing kidney organoids, artificial intelligence-assisted models for nephrotoxicity prediction, advanced high-throughput renal screening platforms, biomarker-guided renal safety panels, and microphysiological kidney-on-chip systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33295&type=smp

What Primary Factors Are Fueling The Expansion Of The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market?

An increasing prevalence of kidney-related disorders is anticipated to propel the expansion of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market in the future. These disorders represent conditions that inflict damage upon the kidneys, impeding their capacity to filter blood and uphold the body’s internal balance. The escalation in kidney-related disorders is largely attributed to the growing incidence of diabetes, which detrimentally affects renal blood vessels and impairs their filtering function. Renal toxicity ADME/toxicology testing plays a crucial role in detecting and evaluating potential kidney damage caused by various drugs or chemicals, thereby enabling timely intervention and the development of more secure treatments. For instance, in 2025, the American Cancer Society, a US-based professional organization, forecasts that approximately 80,980 new cases of kidney (renal) cancer will be diagnosed in the US, with an estimated 14,510 deaths attributed to the disease. Therefore, the increasing occurrence of kidney-related disorders is a significant factor driving the growth of the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market.

What Key Segment Areas Are Included In The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Assessment?

The renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market covered in this report is segmented –

1) By Test Type: In Vitro Renal Toxicity Testing; In Vivo Renal Toxicity Testing; In Silico Renal Toxicity Modeling

2) By Method: Biochemical and Enzymatic Assays; Cell Based Renal Assays; Biomarker Based Toxicity Analysis; Histopathology and Imaging; Pharmacokinetic and Drug Metabolism Studies

3) By Stage of Drug Development: Discovery and Lead Optimization; Preclinical Development; Clinical Development; Post Marketing Safety Studies

4) By Technology: High Throughput Screening Platforms; Organ On Chip and Microfluidic Systems; Omics Based Toxicology Platforms; Artificial Intelligence and Predictive Modeling Tools; Digital Pathology and Imaging Systems

5) By End User: Pharmaceutical and Biotechnology Companies; Contract Research Organizations; Academic and Research Institutes; Regulatory Laboratories

Subsegments:

1) By In Vitro Renal Toxicity Testing: Primary Renal Cell Assays; Immortalized Renal Cell Line Assays; Three Dimensional Renal Cell Cultures; Kidney Organoid Models; Transporter Interaction Assays; Biomarker Based Nephrotoxicity Assays; High Content Imaging Assays; Microphysiological Kidney System Models

2) By In Vivo Renal Toxicity Testing: Acute Renal Toxicity Studies; Subacute Renal Toxicity Studies; Subchronic Renal Toxicity Studies; Chronic Renal Toxicity Studies; Renal Biomarker Evaluation Studies; Histopathological Kidney Assessment; Dose Response Toxicity Studies; Recovery and Reversibility Studies

3) By In Silico Renal Toxicity Modeling: Quantitative Structure Activity Relationship Modeling; Machine Learning Based Toxicity Prediction; Physiologically Based Pharmacokinetic Modeling; Virtual Screening for Nephrotoxicity; Read Across Toxicity Modeling; Systems Biology Based Toxicity Modeling

Which Trends Are Shaping The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Landscape?

Major companies engaged in the renal toxicity-absorption, distribution, metabolism, and excretion (ADME) toxicology testing market are concentrating on developing innovative solutions, such as low-drug-absorbing microfluidic chips. These advancements aim to enhance the predictive accuracy of kidney toxicity while simultaneously reducing the need for animal testing. A low-drug-absorbing microfluidic chip refers to a lab-on-a-chip system designed for renal toxicity assessment that minimizes the unintended absorption of drugs by the chip’s material, thereby ensuring a more accurate simulation of kidney functions and reliable measurement of drug effects on renal cells. For instance, in September 2024, Emulate Inc., a US-based biotechnology company, launched the chip-R1 rigid chip to improve kidney toxicity testing with more precise and dependable results. This chip is constructed for accurate ADME and toxicology modeling in non-stretch organs like the liver and kidney, employing low-drug-absorbing plastics and a thin, porous polycarbonate membrane to prevent compound loss and boost drug recovery for lipophilic compounds. Its benefits include robust shear stress support (up to 2.3 dyn/cm²), preactivated surfaces for simplified workflows, and improved cellular crosstalk, while advantages encompass enhanced reproducibility, precise toxicity detection, and compatibility with current organ-chip hardware to accelerate human-relevant preclinical testing.

Who Are The Leading Firms Participating In The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market?

Major companies operating in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market are Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., WuXi AppTec Co. Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Pharmaron Beijing Co. Ltd., Simulations Plus Inc., GVK Biosciences Pvt. Ltd., Promega Corporation, Syngene International Ltd., SAI Life Sciences Ltd., QPS Holdings LLC, Southern Research Institute, BioIVT LLC, TCG Lifesciences Pvt. Ltd., Frontage Laboratories Inc., Symeres, TSRL Inc., BOC Sciences LLC, Vivisciences Preclinical CRO.

Access The Complete Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Report:

https://www.thebusinessresearchcompany.com/report/renal-toxicity-absorption-distribution-metabolism-and-excretion-adme-toxicology-testing-market-report

Which Region Accounts For The Highest Share Of The Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market?

North America was the largest region in the renal toxicity-ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the renal toxicity – absorption, distribution, metabolism, and excretion (adme) toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Renal Toxicity – Absorption, Distribution, Metabolism, And Excretion (ADME) Toxicology Testing Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model